The Northeast Pulmonary Teaching Conference

The American Lung Association of Central New York  

Patrick Dunn, RRT

            

Patrick J. Dunne, a registered respiratory therapist, is a Sr. Clinical Application Specialist with HealthCare Productions, Inc., a California-based training, research and development network serving health care providers worldwide.  Prior to establishing HealthCare Productions in early 2000, Patrick served as a Regional President and Director of Corporate Compliance for a 19 location, full-service regional provider of home medical and respiratory therapy equipment services.

Before entering the home care field in 1983, Mr. Dunne was involved in respiratory care education at the community college level.  In that capacity, he served, at varying times, as a classroom instructor, clinical coordinator, and program director.  In addition to his classroom and clinic responsibilities, Patrick was also involved in curriculum development, programmatic accreditation, and academic affairs.  Between 1979-83, as a Trustee of the National Board for Respiratory Care (NBRC), he was instrumental in the development and implementation of standardized national credentialing examinations for respiratory therapists.

Following several years of voluntary work on the Board of Directors, in 1991 Mr. Dunne was elected to serve as President of the American Association for Respiratory Care (AARC).  Since that time, Patrick has continued to serve the AARC in various capacities.  He currently serves as a member of the Program Committee for AARC’s 2004 International Congress and is a member of the Board of Directors of the American Respiratory Care Foundation (ACRF), the philanthropic subsidiary of the AARC. 

A part-time home care surveyor/consultant for the JCAHO during 1988-91, in 1992 Patrick was appointed to a 4-year term on the Joint Commission’s Home Care Professional-Technical Advisory Committee (P-TAC).  In December 2001, Patrick was appointed to a three-year term on the Board of Review of the Community Health Accreditation Program (CHAP) and he also serves CHAP as a consultative trainer.

Mr. Dunne attended UCLA where he earned both his undergraduate (1974) and graduate (1979) degrees.  He is also a graduate of the Respiratory Care Program at the Hospital of the University of Pennsylvania.  Patrick has lectured extensively and conducted more than 300 educational workshops throughout North America, Europe, and the Pacific Rim on topics related to clinical respiratory care,  outcomes assessment, evidence-based clinical protocols and corporate compliance/integrity monitoring.

Patrick has published extensively in both the scientific and trade literature, authoring over 50 papers. He is co-author of the popular textbook Respiratory Home Care: The Essentials, published by F.A. Davis in 1998, and also serves as a member of the Editorial Board of Respiratory Care, the official peer-review scientific journal of the AARC. 

In 1998, Patrick was elected a Fellow of the AARC, and in 1999, he was the recipient of the Invacare Award for Excellence in Home Respiratory Care.  In October 2000, Patrick was presented the Jimmy A. Young Medal, the AARC’s highest award for meritorious career service.  Patrick can be reached at his office (714.870.4440), or via E-mail (pjdunne@sbcglobal.net). (November 2003)

Pharmacoeconomics: Justifying New Drugs and Devices

Overview:            
Aerosol therapy continues to undergo a renaissance with new devices and newer pharmacologic agents combining to push the traditional boundaries of this time-honored therapeutic modality.  This presentation will describe the newer technologies used to produce therapeutic aerosols and the advantage these devices might offer over more traditional devices and agents.  The use of pharmacoeconomics to justify the adoption of newer devices and/or agents will also be discussed.  

Objectives:            
At the conclusion of this presentation, those in attendance will be able to:

bullet

Describe the newer technologies used to provide rescue bronchodilation;

bullet

State the importance of using pharmacoeconomic data to support the adoption of newer aerosol treatment modalities;

bullet

Describe at least two types of pharmacoeconomics data that can be used to demonstrate a positive cost-benefit of newer technology 

 

Home Who we are Program Program Committee Faculty Registration Form Sponsors Accreditation Accomodations

For more program information, contact Glenn Ivers at the American Lung Association of Central New York at 506 East Washington Street, Syracuse, NY 13202-1940   tel: 315-422-6142   
e-mail: Russ Acevedo, Program Chair and Webmaster
              Glenn Ivers, Committee Chair: glenn@nepulmonaryconf.com